Yano, Hiroshi <br/><br/>
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells.  [electronic resource] 

 -  Journal of translational medicine  Jul 2014 
 - 191 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-5876 
<br/><br/><label>Standard No.: </label>10.1186/1479-5876-12-191  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bispecific--immunology<br/>Antibodies, Monoclonal--immunology<br/>CD3 Complex--immunology<br/>CTLA-4 Antigen--immunology<br/>Cell Line, Tumor<br/>Humans<br/>Ipilimumab<br/>T-Lymphocytes--immunology